BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors
Garrett W. Rhyasen(AstraZeneca (United States)), Huawei Chen(Shaoxing University)
Cited by 54
Related Papers
Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast Cancer
|Cancer Research|2018|45
Microbial community change and quality improve via endophytic colonization of tobacco by Saccharomyces cerevisiae
|Industrial Crops and Products|2024|10